European Society for Medical Oncology Congress

The latest news from ESMO, including researcher interviews and physician perspective.


Meeting NewsPerspective

Abiraterone acetate offers no survival advantage over docetaxel for prostate cancer

September 8, 2017
MADRID — Abiraterone acetate with prednisone provided no significant difference in OS compared with docetaxel for men with high-risk prostate…
Meeting NewsPerspective

Nearly a quarter of women with small breast cancers at risk for distant metastases

September 8, 2017
MADRID — Nearly one-quarter of women with small breast cancers are at risk for distant metastases and may derive benefit from adjuvant…
Meeting NewsPerspective

Hybrid minimally invasive esophagectomy reduces morbidity in esophageal cancer

September 8, 2017
MADRID — Hybrid minimally invasive esophagectomy reduced incidence of major morbidity compared with open esophagectomy for patients with…
Meeting News

Maintenance rucaparib extends PFS in recurrent ovarian cancer

September 8, 2017
MADRID — Maintenance therapy with rucaparib significantly extended PFS compared with placebo among women with platinum-sensitive recurrent…
Meeting News CoverageVideo

VIDEO: Research into immunotherapy combinations makes ‘great strides’ at ESMO

October 28, 2016
COPENHAGEN, Denmark — Omid Hamid, MD, chief of translational research and immunotherapy and director of melanoma therapeutics at The Angeles…
Meeting News CoverageVideo

VIDEO: Pembrolizumab plus chemotherapy improves response rate, survival in NSCLC

October 18, 2016
COPENHAGEN, Denmark — Corey J. Langer, MD, director of the thoracic oncology program at Abramson Cancer Center of University of Pennsylvania…
Meeting News CoverageVideo

VIDEO: Pembrolizumab may ‘irrevocably alter’ the treatment landscape of NSCLC

October 14, 2016
COPENHAGEN, Denmark — Corey J. Langer, MD, director of thoracic oncology at University of Pennsylvania Abramson Cancer Center and professor of…
Meeting News CoverageVideo

VIDEO: CABOSUN trial ‘changes the game’ of first-line renal cell carcinoma therapy

October 12, 2016
COPENHAGEN, Denmark — Results from the CABOSUN trial may be a “game changer” in the first-line treatment of metastatic renal cell…
Meeting News Coverage

Novel BRCA testing model reduces wait, increases patient satisfaction

October 12, 2016
COPENHAGEN, Denmark — A novel BCRA1/2 testing and counseling model expedited time to receive germline testing results and increased patient…
Meeting News Coverage

FOLFOXIRI plus bevacizumab improves response rate, PFS in advanced colorectal cancer

October 12, 2016
COPENHAGEN, Denmark —The addition of irinotecan to FOLFOX chemotherapy and bevacizumab improved response rates and prolonged PFS for the…